Literature DB >> 11895491

Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma.

M Stewart1, K Talks, R Leek, H Turley, F Pezzella, A Harris, K Gatter.   

Abstract

AIMS: Angiogenesis in solid tumour pathology is well established but less is known about its role in haematological malignancies. Our study investigated the immunohistochemical expression of a variety of angiogenic and hypoxic factors and microvessel densities on 110 cases of high- and low-grade non-Hodgkin's lymphomas and reactive lymphoid tissues. methods and results: Expression of vascular endothelial growth factor (VEGF) was present in 82 (96%) of the non-Hodgkin's cases and 35 (100%) of the reactive lymphoid tissue cases. Both hypoxia inducible factors 1 alpha and 2 alpha (HIF 1 alpha, 2 alpha) were weakly expressed in the majority of high- and low-grade lymphomas. Carbonic anhydrase IX (CA IX), a HIF-inducible membrane-bound enzyme, expression was not abundant with membranous staining being present in seven (8%) of the lymphoma cases and none of the reactive cases. Thymidine phosphorylase (TP) was distributed amongst macrophages and follicular dendritic cells but was not present in the neoplastic population. The vasculature was stained using CD34 which gave rise to a distinct vascular, predominantly paracortical network present in low-grade lymphomas and reactive lymphoid tissue but which was lost in high-grade lymphomas.
CONCLUSION: Our results suggest that non-Hodgkin's lymphomas may be less angiogenic and hypoxically driven than most solid tumours, which has implications for possible future therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895491     DOI: 10.1046/j.1365-2559.2002.01357.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  18 in total

1.  Angiogenesis in nodal B cell lymphomas: a high throughput study.

Authors:  Alexandar Tzankov; Simone Heiss; Stephanie Ebner; William Sterlacci; Georg Schaefer; Florian Augustin; Michael Fiegl; Stephan Dirnhofer
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Expression of hypoxia-inducible carbonic anhydrases in brain tumors.

Authors:  Martin A Proescholdt; Christina Mayer; Marion Kubitza; Thomas Schubert; Shu-Yuan Liao; Eric J Stanbridge; Sergey Ivanov; Edward H Oldfield; Alexander Brawanski; Marsha J Merrill
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

3.  Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: studies on two strains C57/BL6 and BALB/C.

Authors:  Mari Leppilampi; Tuomo J Karttunen; Jyrki Kivelä; Marta Ortova Gut; Silvia Pastoreková; Jaromir Pastorek; Seppo Parkkila
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

4.  Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models.

Authors:  Liu Qi Chen; Christine M Howison; Catherine Spier; Alison T Stopeck; Scott W Malm; Mark D Pagel; Amanda F Baker
Journal:  Leuk Lymphoma       Date:  2014-11-10

5.  Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.

Authors:  Frederik Wein; Teresa Otto; Pascal Lambertz; Joachim Fandrey; Martin-Leo Hansmann; Ralf Küppers
Journal:  Haematologica       Date:  2015-07-09       Impact factor: 9.941

Review 6.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

7.  In vivo and in vitro effects of a HIF-1alpha inhibitor, RX-0047.

Authors:  Z Gunnur Dikmen; Ginelle C Gellert; Pakize Dogan; Heejeong Yoon; Young Bok Lee; Chang Ho Ahn; Jerry W Shay
Journal:  J Cell Biochem       Date:  2008-06-01       Impact factor: 4.429

8.  Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family.

Authors:  Andrew M Evens; Paul T Schumacker; Irene B Helenowski; Amareshwar T K Singh; Danijela Dokic; Anjeni Keswani; Elizabeth Kordeluk; Adekunle Raji; Jane N Winter; Borko D Jovanovic; Arne Holmgren; Beverly P Nelson; Leo I Gordon
Journal:  Br J Haematol       Date:  2008-04-15       Impact factor: 6.998

9.  Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance.

Authors:  H R De Raeve; P B Vermeulen; K Vanderkerken; A L Harris; E Van Marck
Journal:  Virchows Arch       Date:  2004-05-28       Impact factor: 4.064

10.  Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).

Authors:  Kristen Ganjoo; Fangxin Hong; Sandra J Horning; Randy D Gascoyne; Yasodha Natkunam; Lode J Swinnen; Thomas M Habermann; Brad S Kahl; Ranjana H Advani
Journal:  Leuk Lymphoma       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.